Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBSE Current Ratio

The Current Ratio of NeuBase Therapeutics Inc (NBSE) is 8.36.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

NBSE Current Ratio - Historical Value
Date Value
2022-12-31 8.36
2022-09-30 5.91
2021-09-30 13.11
2020-09-30 10.42
2019-09-30 4.41
2018-09-30 5.48
2017-09-30 2.64
2016-09-30 2.97
2015-09-30 7.48
2014-09-30 2.53
NBSE Current Ratio - Peers Comparison